MNK

Mallinckrodt Plc
NYSE

Real-time Quotes | Nasdaq Last Sale

2.870
+0.780
+37.32%
After Hours: 2.870 0 0.00% 19:38 04/08 EDT
OPEN
2.140
PREV CLOSE
2.090
HIGH
2.900
LOW
2.110
VOLUME
16.24M
TURNOVER
--
52 WEEK HIGH
23.90
52 WEEK LOW
1.000
MARKET CAP
241.68M
P/E (TTM)
-0.2398
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 12 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MNK stock price target is 3.030 with a high estimate of 6.00 and a low estimate of 1.000.

EPS

MNK News

More
  • Mallinckrodt shares halted pending news
  • seekingalpha · 1d ago
  • Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue
  • Zacks · 1d ago
  • Mallinckrodt Stock Is Soaring on Refinancing of Debt
  • Barrons.com · 1d ago
  • Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
  • Barrons.com · 1d ago

Industry

Pharmaceuticals
+2.77%
Pharmaceuticals & Medical Research
+2.82%

Hot Stocks

Symbol
Price
%Change

About MNK

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
More

Webull offers kinds of Mallinckrodt Plc stock information, including NYSE:MNK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNK stock news, and many more online research tools to help you make informed decisions.